Sun Pharma’s net profit rises 13% in September quarter

Drug major Sun Pharmaceutical Industries posted a 13% rise in its consolidated net profit for the quarter ended September 2021 to ₹2,047 crore as compared to ₹1,812.7 crore in the same quarter last year. Shares of Sun Pharma were trading over 0.3% higher at ₹814.7 apiece on the BSE in Tuesday’s afternoon deals.

The Mumbai-based drugmaker’s total revenue from operations rose 12.5% to ₹9,626 crore from ₹8,553 crore year-on-year (YoY). Its tax expenses slipped to ₹198 crore versus ₹257 crore on a like-to-like basis.

“The Group continues to monitor the impact of Covid-19 on its business, including its impact on customers, supply-chain, employees and logistics,” the pharma giant said in an exchange filing.

Sun Pharma share price has advanced 38% this year, outpacing the 26% rise of benchmark S&P BSE Sensex Index. 


Subscribe to Mint Newsletters * Enter a valid email * Thank you for subscribing to our newsletter.

Never miss a story! Stay connected and informed with Mint.
our App Now!!

Source link

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button
%d bloggers like this: